The lack of transparency, trustworthiness, and reliability has been an overarching problem of the CBD industry that hurts both...
Category - Legislation and Policy
FDA Approves More Uses for Epidiolex
As of July 2020, the FDA has approved an additional use for the cannabidiol-derived drug Epidiolex as an oral solution for the...
FDA’s CBD Accuracy Report
Since cannabidiol (CBD) was federally legalized back in 2018, there’s been a major push for more regulations under the Food and...
The Pentagon Forbids Troops to Use CBD
CBD, along with cannabis altogether, has been proving to be a refreshing change from prescription medications for PTSD and other...
Cannabinoid Sales in Germany Climb to €15 million in March
According to a recent Prohibition Partners report, German cannabinoid sales reached record levels in Q1 2020, signaling a shift...
CBD Markets Poised for Growth in Brazil
Make no mistake about it, CBD is quickly becoming a global phenomenon with massive economic potential. This unabated growth has...
CBD, Pain, & Opioid Use
The majority of studies published on the relationship between medical cannabis and opioids have shown that cannabinoids can both...
Lessons from Prohibition
In 1937, cannabis officially became ‘persona non grata’ to the United States government — a marked shift from the cozy...
The Unique Challenges and Opportunities of CBD-Infused Food Products
Despite CBD’s massive surge in popularity and the differentiation of various niches within this exciting new market, a major...
The MORE Act Looking to Change Federal Laws on Cannabis
Across the US, cannabis is being legalized one state at a time, now with 33 states having legalized medical cannabis and 11...